Approach China Medical With Caution
China Medical has long-term prospects, but they come with short-term risks.
Financial research is never a simple task. It requires a substantial time commitment to read over a company's recent filings and listen to its investor presentation, as well as to get a feel for the industry and sector as a whole. But, even the most bullish research should be viewed with a cautious eye.
One name to be leery of here is
China Medical
(CMED)
, which currently has 27 million shares outstanding. Based in Beijing, China, the medical device company manufactures and markets products using high-intensity focused ultrasound, or HIFU, for the treatment of solid cancers and benign tumors.
To read more,
.
Stockpickr is a wholly owned subsidiary of TheStreet.com.
